Big Pharma’s ‘Appalling’ $26 Billion in Shareholder Payouts Could Fund Vaccines for All of Africa: Report

Big Pharma’s ‘Appalling’ $26 Billion in Shareholder Payouts Could Fund Vaccines for All of Africa: Report

Pfizer, Johnson & Johnson, and AstraZeneca—three of the world’s top coronavirus vaccine manufacturers—have paid out a combined $26 billion in dividends and stock buybacks to their shareholders over the past year, a sum that could fully fund the cost of inoculating Africa’s entire 1.3 billion-person population.

That’s according to an analysis released Thursday morning by the People’s Vaccine Alliance, a coalition of advocacy organizations campaigning to end massive inequities in the distribution of life-saving coronavirus vaccines.

0
Like
Save
Subscribe to Realnews.Today Daily DigestGet RealNews.Today digest of the day every day in your inbox

Sign up to get Realnews.Today updates to get the summary of important news every day in your inbox.